Contact Us
Metagenomics In Healthcare Global Market Report 2025
Global Metagenomics In Healthcare Market Report 2025
Item added to cart!

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Metagenomics In Healthcare Global Market Report 2025

By Types (Sample Extraction Kits, Metagenomics Kits); By Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Microarray); By Workflow (Sample Collection, Deoxyribonucleic Acid Extraction, Library Preparation, Sequencing); By Application (Infectious Disease Diagnosis, Genomic Epidemiology, Personalized Medicine, Microbiome Analysis, Drug Discovery); By End User (Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Biotechnology Companies); Subsegments:; By Sample Extraction Kits (Deoxyribonucleic Acid Extraction Kits, Ribonucleic Acid Extraction Kits, Protein Extraction Kits); By Metagenomics Kits (Library Preparation Kits, Sequencing Kits, Target Enrichment Kits) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Metagenomics In Healthcare Market Overview

• Metagenomics In Healthcare market size has reached to $2.07 billion in 2024

• Expected to grow to $4.66 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%

• Growth Driver: Increasing Prevalence Of Infectious Diseases Fueling The Growth Of The Market Due To Rising Pathogen Spread And Need For Rapid, Accurate Diagnostics

• Market Trend: Innovative Solutions Drive Advanced Disease Diagnostics

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Metagenomics In Healthcare Market?

Metagenomics in healthcare is the study of genetic material recovered directly from clinical or environmental samples to analyze entire microbial communities without the need for culturing. It helps to identify pathogens, understand microbiome composition, and detect disease-associated microbial shifts, enabling precise diagnosis, personalized treatment, and improved infection management.

The main types of metagenomics in healthcare are sample extraction kits and metagenomics kits. Sample extraction kits refer to commercially available kits designed to isolate deoxyribonucleic acid or ribonucleic acid from biological samples efficiently and reliably. It utilizes technologies, including next-generation sequencing, polymerase chain reaction, and microarray, and has different workflows including sample collection, deoxyribonucleic acid extraction, library preparation, and sequencing. It finds applications in infectious disease diagnosis, genomic epidemiology, personalized medicine, microbiome analysis, and drug discovery, serving end users such as hospitals, diagnostic laboratories, research institutes, pharmaceutical companies, and biotechnology companies.

Metagenomics In Healthcare Market Size and growth rate 2025 to 2029: Graph

What Is The Metagenomics In Healthcare Market Size 2025 And Growth Rate?

The metagenomics in healthcare market size has grown rapidly in recent years. It will grow from $2.07 billion in 2024 to $2.44 billion in 2025 at a compound annual growth rate (CAGR) of 17.9%. The growth in the historic period can be attributed to rising adoption of bioinformatics tools to analyze complex metagenomic data, rising adoption of bioinformatics tools to analyze complex metagenomic data, rising need for rapid and accurate pathogen detection methods, rising need for rapid and accurate pathogen detection methods, and growing use of metagenomics in drug discovery and biomarker identification.

What Is The Metagenomics In Healthcare Market Growth Forecast?

The metagenomics in healthcare market size is expected to see rapid growth in the next few years. It will grow to $4.66 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to increasing prevalence of infectious diseases, increasing demand for precision medicine, increasing focus on antimicrobial resistance surveillance using metagenomics, increasing applications of metagenomics in oncology research and diagnostics, and rising awareness about microbiome-based therapies and interventions. Major trends in the forecast period include technology advancements in sequencing platforms, innovations in bioinformatics pipelines, developments in single-cell metagenomics, research and development in microbiome therapeutics, and integration of artificial intelligence in data analysis.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How the Metagenomics In Healthcare Market Segmented?

1) By Types: Sample Extraction Kits, Metagenomics Kits

2) By Technology: Next-Generation Sequencing, Polymerase Chain Reaction, Microarray

3) By Workflow: Sample Collection, Deoxyribonucleic Acid Extraction, Library Preparation, Sequencing

4) By Application: Infectious Disease Diagnosis, Genomic Epidemiology, Personalized Medicine, Microbiome Analysis, Drug Discovery

5) By End User: Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Biotechnology Companies

Subsegments:

1) By Sample Extraction Kits: Deoxyribonucleic Acid Extraction Kits, Ribonucleic Acid Extraction Kits, Protein Extraction Kits

2) By Metagenomics Kits: Library Preparation Kits, Sequencing Kits, Target Enrichment Kits

What Is Driving The Metagenomics In Healthcare Market? Increasing Prevalence Of Infectious Diseases Fueling The Growth Of The Market Due To Rising Pathogen Spread And Need For Rapid, Accurate Diagnostics

The increasing prevalence of infectious diseases is expected to propel the growth of the metagenomics in healthcare market going forward. Infectious diseases refer to illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can spread directly or indirectly from one person to another. The rising prevalence of infectious diseases is due to increased travel, which facilitates the rapid spread of pathogens across borders. Metagenomics in healthcare helps combat infectious diseases by enabling rapid and precise identification of pathogens, making it crucial for controlling infectious outbreaks. It reduces diagnostic uncertainty by analyzing complex microbial communities, improving patient outcomes and guiding targeted treatments. For instance, in February 2024, according to the UK Health Security Agency, a UK-based government agency, tuberculosis (a contagious bacterial infection that primarily affects the lungs) cases in England rose to 4,850 in 2023, an increase of 10.7% from 4,380 cases in 2022. Therefore, the increasing prevalence of infectious diseases is driving the growth of the metagenomics in healthcare industry.

Who Are The Major Players In The Global Metagenomics In Healthcare Market?

Major companies operating in the metagenomics in healthcare market are F. Hoffmann-La Roche AG, Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., BGI Genomics Co. Ltd., Novogene Corporation, Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., MedGenome Labs Limited, Zymo Research Corporation, BaseClear B.V., Psomagen Inc., Karius Inc., Microsynth AG, Macrogen Inc., Norgen Biotek Corp., Tiny Health Inc., CosmosID Inc., Kanvas Biosciences Inc., Phase Genomics Inc., and Wobble Genomics Inc.

What Are The Key Trends Of The Global Metagenomics In Healthcare Market? Innovative Solutions Drive Advanced Disease Diagnostics

Major companies operating in the metagenomics in healthcare market are focusing on developing innovative solutions, such as microbial community profiling, to enhance disease diagnostics, enable personalized therapies, and advance precision medicine. Microbial community profiling refers to the comprehensive analysis and characterization of diverse microbial populations within a specific environment or sample, using sequencing and bioinformatics tools to identify their composition, diversity, and functional roles. For instance, in August 2024, MGI Tech Co. Ltd., a China-based biotechnology company, launched a Human Microbiome Metagenomics Sequencing Package to advance microbial research and healthcare applications. It delivers an automated, end-to-end microbial community profiling workflow for efficiently analyzing human microbiome diversity, function, and disease links using validated high-throughput platforms. It minimizes manual labor, enhances reproducibility, and reduces costs, making large-scale and clinical microbiome research more accessible. The researchers gain advantages from fast and precise microbial identification, along with adaptable throughput, facilitating biomarker discovery and advancing translational health research.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Metagenomics In Healthcare Market? Lupin Limited And Avas Pharmaceuticals SRL Collaborate To Introduce First Licensed Treatment For Myotonia In Italy

In May 2025, Mapmygenome India Limited, an India-based genomics and diagnostics company, acquired Microbiome Insights Inc. for an undisclosed amount. With this acquisition, Mapmygenome aims to expand its capabilities in microbiome sequencing and analysis, strengthen its presence in the North American market, and enhance its offerings in personalized health, genomics, and research services. Microbiome Insights Inc. is a Canada-based biotechnology company that offers metagenomics in healthcare.

What Is The Regional Outlook For The Global Metagenomics In Healthcare Market?

North America was the largest region in the metagenomics in healthcare market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Metagenomics In Healthcare Market?

The metagenomics in healthcare market consists of revenues earned by entities by providing services such as bioinformatics analysis, microbial diagnostics, and drug discovery support. The market value includes the value of related goods sold by the service provider or included within the service offering. The metagenomics in the healthcare market also includes sales of sequencing platforms, reagents, consumables, and bioinformatics tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Metagenomics In Healthcare Industry?

The metagenomics in healthcare market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the metagenomics in healthcare industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Table Of Contents

1. Executive Summary

2. Metagenomics In Healthcare Market Characteristics

3. Metagenomics In Healthcare Market Trends And Strategies

4. Metagenomics In Healthcare Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Metagenomics In Healthcare Growth Analysis And Strategic Analysis Framework

5.1. Global Metagenomics In Healthcare PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Metagenomics In Healthcare Market Growth Rate Analysis

5.4. Global Metagenomics In Healthcare Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Metagenomics In Healthcare Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Metagenomics In Healthcare Total Addressable Market (TAM)

6. Metagenomics In Healthcare Market Segmentation

6.1. Global Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Sample Extraction Kits

Metagenomics Kits

6.2. Global Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Next-Generation Sequencing

Polymerase Chain Reaction

Microarray

6.3. Global Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Sample Collection

Deoxyribonucleic Acid Extraction

Library Preparation

Sequencing

6.4. Global Metagenomics In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Infectious Disease Diagnosis

Genomic Epidemiology

Personalized Medicine

Microbiome Analysis

Drug Discovery

6.5. Global Metagenomics In Healthcare Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Diagnostic Laboratories

Research Institutes

Pharmaceutical Companies

Biotechnology Companies

6.6. Global Metagenomics In Healthcare Market, Sub-Segmentation Of Sample Extraction Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Deoxyribonucleic Acid Extraction Kits

Ribonucleic Acid Extraction Kits

Protein Extraction Kits

6.7. Global Metagenomics In Healthcare Market, Sub-Segmentation Of Metagenomics Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Library Preparation Kits

Sequencing Kits

Target Enrichment Kits

7. Metagenomics In Healthcare Market Regional And Country Analysis

7.1. Global Metagenomics In Healthcare Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Metagenomics In Healthcare Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Metagenomics In Healthcare Market

8.1. Asia-Pacific Metagenomics In Healthcare Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Metagenomics In Healthcare Market

9.1. China Metagenomics In Healthcare Market Overview

9.2. China Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Metagenomics In Healthcare Market

10.1. India Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Metagenomics In Healthcare Market

11.1. Japan Metagenomics In Healthcare Market Overview

11.2. Japan Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Metagenomics In Healthcare Market

12.1. Australia Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Metagenomics In Healthcare Market

13.1. Indonesia Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Metagenomics In Healthcare Market

14.1. South Korea Metagenomics In Healthcare Market Overview

14.2. South Korea Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Metagenomics In Healthcare Market

15.1. Western Europe Metagenomics In Healthcare Market Overview

15.2. Western Europe Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Metagenomics In Healthcare Market

16.1. UK Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Metagenomics In Healthcare Market

17.1. Germany Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Metagenomics In Healthcare Market

18.1. France Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Metagenomics In Healthcare Market

19.1. Italy Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Metagenomics In Healthcare Market

20.1. Spain Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Metagenomics In Healthcare Market

21.1. Eastern Europe Metagenomics In Healthcare Market Overview

21.2. Eastern Europe Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Metagenomics In Healthcare Market

22.1. Russia Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Metagenomics In Healthcare Market

23.1. North America Metagenomics In Healthcare Market Overview

23.2. North America Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Metagenomics In Healthcare Market

24.1. USA Metagenomics In Healthcare Market Overview

24.2. USA Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Metagenomics In Healthcare Market

25.1. Canada Metagenomics In Healthcare Market Overview

25.2. Canada Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Metagenomics In Healthcare Market

26.1. South America Metagenomics In Healthcare Market Overview

26.2. South America Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Metagenomics In Healthcare Market

27.1. Brazil Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Metagenomics In Healthcare Market

28.1. Middle East Metagenomics In Healthcare Market Overview

28.2. Middle East Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Metagenomics In Healthcare Market

29.1. Africa Metagenomics In Healthcare Market Overview

29.2. Africa Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Metagenomics In Healthcare Market Competitive Landscape And Company Profiles

30.1. Metagenomics In Healthcare Market Competitive Landscape

30.2. Metagenomics In Healthcare Market Company Profiles

30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Metagenomics In Healthcare Market Other Major And Innovative Companies

31.1. QIAGEN N.V.

31.2. BGI Genomics Co. Ltd.

31.3. Novogene Corporation

31.4. Oxford Nanopore Technologies Limited

31.5. Pacific Biosciences of California Inc.

31.6. MedGenome Labs Limited

31.7. Zymo Research Corporation

31.8. BaseClear B.V.

31.9. Psomagen Inc.

31.10. Karius Inc.

31.11. Microsynth AG

31.12. Macrogen Inc.

31.13. Norgen Biotek Corp.

31.14. Tiny Health Inc.

31.15. CosmosID Inc.

32. Global Metagenomics In Healthcare Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Metagenomics In Healthcare Market

34. Recent Developments In The Metagenomics In Healthcare Market

35. Metagenomics In Healthcare Market High Potential Countries, Segments and Strategies

35.1 Metagenomics In Healthcare Market In 2029 - Countries Offering Most New Opportunities

35.2 Metagenomics In Healthcare Market In 2029 - Segments Offering Most New Opportunities

35.3 Metagenomics In Healthcare Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Metagenomics In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Metagenomics In Healthcare Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Metagenomics In Healthcare Market, Sub-Segmentation Of Sample Extraction Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Metagenomics In Healthcare Market, Sub-Segmentation Of Metagenomics Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Metagenomics In Healthcare Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Metagenomics In Healthcare Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: F. Hoffmann-La Roche AG Financial Performance
  • Table 79: Eurofins Scientific Financial Performance
  • Table 80: Agilent Technologies Inc. Financial Performance
  • Table 81: Illumina Inc. Financial Performance
  • Table 82: Bio-Rad Laboratories Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Metagenomics In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Metagenomics In Healthcare Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Metagenomics In Healthcare Market, Sub-Segmentation Of Sample Extraction Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Metagenomics In Healthcare Market, Sub-Segmentation Of Metagenomics Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Metagenomics In Healthcare Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Metagenomics In Healthcare Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: F. Hoffmann-La Roche AG Financial Performance
  • Figure 79: Eurofins Scientific Financial Performance
  • Figure 80: Agilent Technologies Inc. Financial Performance
  • Figure 81: Illumina Inc. Financial Performance
  • Figure 82: Bio-Rad Laboratories Inc. Financial Performance

Frequently Asked Questions

Metagenomics in healthcare is the study of genetic material recovered directly from clinical or environmental samples to analyze entire microbial communities without the need for culturing. It helps to identify pathogens, understand microbiome composition, and detect disease-associated microbial shifts, enabling precise diagnosis, personalized treatment, and improved infection management. For further insights on this market, request a sample here

The market major growth driver - Increasing Prevalence Of Infectious Diseases Fueling The Growth Of The Market Due To Rising Pathogen Spread And Need For Rapid, Accurate Diagnostics. For further insights on this market, request a sample here

The metagenomics in healthcare market size has grown rapidly in recent years. It will grow from $2.07 billion in 2024 to $2.44 billion in 2025 at a compound annual growth rate (CAGR) of 17.9%. The growth in the historic period can be attributed to rising adoption of bioinformatics tools to analyze complex metagenomic data, rising adoption of bioinformatics tools to analyze complex metagenomic data, rising need for rapid and accurate pathogen detection methods, rising need for rapid and accurate pathogen detection methods, and growing use of metagenomics in drug discovery and biomarker identification. The metagenomics in healthcare market size is expected to see rapid growth in the next few years. It will grow to $4.66 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to increasing prevalence of infectious diseases, increasing demand for precision medicine, increasing focus on antimicrobial resistance surveillance using metagenomics, increasing applications of metagenomics in oncology research and diagnostics, and rising awareness about microbiome-based therapies and interventions. Major trends in the forecast period include technology advancements in sequencing platforms, innovations in bioinformatics pipelines, developments in single-cell metagenomics, research and development in microbiome therapeutics, and integration of artificial intelligence in data analysis. For further insights on this market, request a sample here

The metagenomics in healthcare market covered in this report is segmented as
1) By Types: Sample Extraction Kits, Metagenomics Kits
2) By Technology: Next-Generation Sequencing, Polymerase Chain Reaction, Microarray
3) By Workflow: Sample Collection, Deoxyribonucleic Acid Extraction, Library Preparation, Sequencing
4) By Application: Infectious Disease Diagnosis, Genomic Epidemiology, Personalized Medicine, Microbiome Analysis, Drug Discovery
5) By End User: Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Biotechnology Companies Subsegments:
1) By Sample Extraction Kits: Deoxyribonucleic Acid Extraction Kits, Ribonucleic Acid Extraction Kits, Protein Extraction Kits
2) By Metagenomics Kits: Library Preparation Kits, Sequencing Kits, Target Enrichment Kits For further insights on this market,
request a sample here

North America was the largest region in the metagenomics in healthcare market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in metagenomics in healthcare report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Major companies operating in the metagenomics in healthcare market are F. Hoffmann-La Roche AG, Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., BGI Genomics Co. Ltd., Novogene Corporation, Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., MedGenome Labs Limited, Zymo Research Corporation, BaseClear B.V., Psomagen Inc., Karius Inc., Microsynth AG, Macrogen Inc., Norgen Biotek Corp., Tiny Health Inc., CosmosID Inc., Kanvas Biosciences Inc., Phase Genomics Inc., and Wobble Genomics Inc. For further insights on this market, request a sample here.

Major trends in this market include Innovative Solutions Drive Advanced Disease Diagnostics For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon